Streptidine, a metabolic derivative produced after administration of streptomycin in vivo, is vestibulotoxic in rats

Histology and Histopathology

Volumn 20, Issue 2, 2005, Pages 357-364

  Granados, O ^a   Meza, Graciela ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Ototoxicity; Streptidine; Streptomycin; Streptomycin derivatives

Indexed keywords

STREPTIDINE; STREPTOMYCIN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; HAIR CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MICROSCOPY; NEUROEPITHELIUM; NONHUMAN; OTOTOXICITY; RAT; SWIMMING; VESTIBULAR DISORDER;

ANIMALS; EPITHELIUM; GUANIDINES; HEXOSAMINES; HUMANS; LOCOMOTION; MALE; RATS; RATS, LONG-EVANS; SACCULE AND UTRICLE; STREPTOMYCIN; SWIMMING; TIME FACTORS; VESTIBULE;

ANIMALIA;

EID: 16344372440     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Akano E., Maekawa T., Uchinashi M. and Kanamori R. (2002). A study of streptomycin blood level information of patients undergoing hemodialysis. Biopharm. Drug Dispos. 23, 47-52.
2. 13C NMR and spectroscopic studies. Structure and bonding properties of the streptidine fraction. J. Inorg. Biochem. 40, 201-215.
3. Bareggi R., Narducci P., Grill V., Mallardi F., Zweyer M. and Fusaroli P. (1986). Localization of an aminoglycoside (streptomycin) in the inner ear after its systemic administration. Histochemistry 84, 237-240.
4. Begg J.E. and Barclay L.M. (1995). Aminoglycosides-50 years on. Br. J. Clin. Pharmacol. 39, 597-603.
5. Crann A.S., Hang Y.M., McLaren D.J. and Schacht J. (1992). Formation of a toxic metabolite from gentamicin by a hepatic cytosolic fraction. Biochem. Pharmacol. 43, 1835-1839.
6. Crann A.S. and Schacht J. (1996). Activation of aminoglycoside antibiotics to cytotoxins. Audiol. Neurootol. 1, 80-85.
7. Fermin C.D., Lychacov D., Campos A., Hara H., Sondag E., Jones T., Jones S., Taylor M., Meza-Ruíz G. and Martin D.S. (1998). Otoconia biogenesis, phylogeny, composition and functional attributes. Histol. Histopathol. 13, 1103-1154.
8. Fee E.W Jr. (1980). Aminoglycoside Ototoxicity in the Human. The Laryngoscope. Suppl. 24, 1-19.
9. Granados O., Meza G. and Barba-Behrens N. (2002). Streptidine is released from streptomycin by enzymatic hydrolysis in the human serum. 12th European Congress of Clinical Microbiology and Infectious Diseases. Abstr. P1078, 241.
10. Huang Y.M. and Schacht J. (1990). Formation of a cytotoxic metabolite from gentamicin by liver. Biochem. Pharmacol. 40, R11-R14.
11. López I., Ayala C. and Honrubia V. (2002). Synaptophysin immunohistochemistry during vestibular hair cell recovery after gentamicin treatment. Audiol. Neurootol. 8, 80-90.
12. Meza G., López I., Paredes M.A., Peñaloza Y. and Poblano A. (1989). Cellular target of streptomycin in the internal ear. Acta Otolatyngol. (Stockh). 107, 406-411.
13. Meza G., Daunton N., Fox R., López-Griego L., Pratt H. and Zepeda H. (1994). Vestibulotoxicity of streptomycin in the pigmented rat. Collegium Otorhinolaryngol. Abstr. 57, 45-46.
14. Meza G., Bohne B., Daunton N., Fox R. and Knox J. (1996). Damage and recovery of otololithic function following streptomycin treatment in the rat. Ann NY Acad. Sci. 781, 666-669.
15. Meza G., Guerra G., Granados O., Barba N., Toxqui A. and Hernández C. (1999). Estreptomicina: propiedades fisicoquímicas y toxicidad vestibular. Ann. Otorrinol. Mexicana 44, 21-25.
16. Meza G., Barba-Behrens N., Granados O., Hernández CA. and Toxqui A. (2001). Vestibular histofluorescence could be due to accumulation of both the antibiotic and its derivative, streptidine, after acute streptomycin treatment in the guinea pig. Histol. Histopathol. 16, 1143-1148.
17. Owada K. (1962). Experimental studies of the toxicity of kanamycin, its hydrolysed products and neomycin. Chemotherapia 5, 277-293.
18. Ross D.M. (1997). Morphological evidence for local microcircuits in rat vestibular maculae. J. Comp. Neurol. 379, 333-346.
19. Sande A.M. and Mandell L.G. (1996). Antimicrobial agents. The Aminoglycosides. In: The pharmacological basis of the therapeutics. 8th ed. Goodman S.L. and Gilman A. (eds). Pergamon Press. New York. pp 1098-1116.
20. Schentag J.J. and Jusko W.J. (1977). Renal clearance and tissue accumulation of gentamicin. Clin. Pharmacol. Ther. 22, 364-370.
21. Strausbaugh L.J., Mandalaris C.D. and Sande A.M. (1977). Comparison of four aminoglycoside antibiotics in the therapy of experimental E. Coli meningitis. J. Lab. Clin. Med. 89, 692-702.
22. Tran Ba Huy P., Manuel C. and Meulemans A. (1981). Kinetics of aminoglycoside antibiotics in perilymph and endolymph in animals. In: Aminoglycoside ototoxicity. 1a ed. Lerner A.S., Matz J.G. and Hawkins E.J Jr. (eds). Little, Brown and Company. Boston. pp 81-98.
23. Trune D.R. and Lim D.J. (1983a). A morphometric study of the pallid mutant mouse inner ear. Am. J. Otolaryngol. 4, 261-272.
24. Trune D.R. and Lim D.J. (1983b). The behavior and vestibular nuclear morphology of otoconia-deficient pallid mutant mice. J. Neurogenet. 1, 53-69.
25. Voldrich L. (1965). The kinetics of streptomycin, kanamycin and neomycin in the inner ear. Acta oto-laryng. 60, 243-248.
26. Wang S., Bian Q., Liu Z., Feng Y., Lian N., Chen H., Hu Ch., Dong Y. and Cai Z. (1999). Capability of serum to convert streptomycin to cytotoxin in patients with aminoglycoside induced hearing loss. Hearing Res. 137, 1-7.
27. Wersäll J. (1995). Ototoxic antibiotics: a review. Acta Otolaryngol (Sctockh) Suppl. 519, 26-29.
28. Whall T.J. (1981). Determination of streptomycin sulfate and dihydrostreptomycin sulfate by high performance liquid chromatography. J. Chromatography 219, 89-100.
29. Williams P.D., Bennett D.B., Gleason C.R. and Hottendorf G.H. (1987). Correlation between renal membrane binding and nephrotoxicity of aminoglycosides. Antimicrob. Agents Chemother. 31, 570-574.